Fairfield Financial Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-105
| Closed | -$490 | – | 292 |
|
|
2024
Q2 | $490 | Buy |
+105
| New | +$490 | ﹤0.01% | 279 |
|
|
2023
Q4 | $8.56K | Buy |
845
+300
| +55% | +$3.04K | ﹤0.01% | 249 |
|
|
2023
Q3 | $4.25K | Hold |
545
| – | – | ﹤0.01% | 261 |
|
|
2023
Q2 | $4.49K | Hold |
545
| – | – | ﹤0.01% | 275 |
|
|
2023
Q1 | $3.83K | Hold |
545
| – | – | ﹤0.01% | 279 |
|
|
2022
Q4 | $4.83K | Hold |
545
| – | – | ﹤0.01% | 253 |
|
|
2022
Q3 | $6.67K | Hold |
545
| – | – | ﹤0.01% | 247 |
|
|
2022
Q2 | $6.45K | Hold |
545
| – | – | ﹤0.01% | 233 |
|
|
2022
Q1 | $10.4K | Buy |
+545
| New | +$10.4K | ﹤0.01% | 219 |
|